Sling Therapeutics Appoints Ken Lock As Chief Commercial Officer
06/18/25, 2:17 PM
Location
Industry
biotechnology
health care
Position
chief commercial officer
Sling Therapeutics, Inc. announces the appointment of Ken Lock as Chief Commercial Officer. He brings over 20 years of commercial leadership experience as the company prepares for its confirmatory Phase 3 study of linsitinib for thyroid eye disease.
Company Info
Location
ann arbor, michigan, united states
Additional Info
Sling Therapeutics is a clinical-stage biopharmaceutical company focused on developing an oral small molecule therapy for the treatment of thyroid eye disease (TED). Our team is composed of seasoned drug development professionals, supported by a global network of experts through our Scientific Advisory Board.
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Kh
Kh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Rh
Rh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more